Faculty Publications
Permanent URI for this communityhttps://idr.nitk.ac.in/handle/123456789/18736
Publications by NITK Faculty
Browse
8 results
Search Results
Item From Pixels to Prognosis: Exploring from UNet to Segment Anything in Mammogram Image Processing for Tumor Segmentation(Institute of Electrical and Electronics Engineers Inc., 2024) Hithesh, M.R.; Vishwanath, V.K.Breast cancer, is the most prevalent form of cancer among women globally accounting for nearly one in four of all new cancer cases. This high prevalence makes breast cancer the second leading cause of death among women making early detection of breast cancer crucial for reducing mortality rates. Mammography, a widely employed medical imaging technique, emerges as a front-line defense against breast cancer. The research aims to achieve pivotal objectives: Firstly, to examine the Segment Anything Model (SAM), created by MetaAI in 2023, and also discuss the model's use in medical image segmentation. Secondly, the study aims to conduct a comprehensive comparative analysis of SAM's segmentation capabilities with other existing segmentation models for medical images. The unique strength of the research lies in incorporating both mass and calcification mammograms within the diverse Curated Breast Imaging Subset of DDSM (CBIS-DDSM) dataset this acknowledges the varied nature of breast cancer, exposing the segmentation models to a wide range of scenarios. Through augmenting the dataset with vertical, horizontal, and rotational transformations, this enables accurate identification and isolation of Region of Interests (RoIs) in mammograms, for robust model training for real-world breast cancer diagnosis. The study investigates different segmentation models for medical image segmentation, with an emphasis on prompt-based (SAM), Encoder-Decoder (UNet, UNet++, Attention-UNet, SegNet) models. The study extends to evaluating these models based on Key Performance Indicators (KPIs) such as Dice score, Intersection over Union (IoU) and Accuracy. The insights gained from this research have broader implications for the application of more accurate segmentation in medical image analysis, and making a significant contribution to the continuous efforts to improve breast cancer diagnostic methodologies. © 2024 IEEE.Item A Comprehensive Survey on Breast Cancer Diagnostics: From Artificial Intelligence to Quantum Machine Learning(Institute of Electrical and Electronics Engineers Inc., 2025) Reddy, M.R.V.S.R.S.; Kumar, S.; Bhowmik, B.Breast cancer remains a leading cause of mortality among women worldwide, where early detection significantly improves survival rates. Traditional diagnostic methods like mammography, biopsy, and ultrasonography face challenges like diagnostic errors and low sensitivity. Recent advancements in Artificial Intelligence (AI), including deep learning for image analysis and natural language processing for patient data interpretation, have shown promise in enhancing diagnostic capabilities. The integration of these AI techniques with Quantum Machine Learning (QML) leverages quantum parallelism to process high-dimensional medical data and extract intricate imaging patterns more efficiently. This paper provides a comprehensive overview of cancer, its subtypes, symptoms, and the limitations of conventional diagnostics while highlighting the transformative potential of QML in improving diagnostic accuracy and efficiency for breast cancer detection and prognosis. © 2025 IEEE.Item Efficient and robust deep learning architecture for segmentation of kidney and breast histopathology images(Elsevier Ltd, 2021) Chanchal, A.K.; Kumar, A.; Lal, S.; Kini, J.Image segmentation is consistently an important task for computer vision and the analysis of medical images. The analysis and diagnosis of histopathology images by using efficient algorithms that separate hematoxylin and eosin-stained nuclei was the purpose of our proposed method. In this paper, we propose a deep learning model that automatically segments the complex nuclei present in histology images by implementing an effective encoder–decoder architecture with a separable convolution pyramid pooling network (SCPP-Net). The SCPP unit focuses on two aspects: first, it increases the receptive field by varying four different dilation rates, keeping the kernel size fixed, and second, it reduces the trainable parameter by using depth-wise separable convolution. Our deep learning model experimented with three publicly available histopathology image datasets. The proposed SCPP-Net provides better experimental segmentation results compared to other existing deep learning models and is evaluated in terms of F1-score and aggregated Jaccard index. © 2021 Elsevier LtdItem A novel deep classifier framework for automated molecular subtyping of breast carcinoma using immunohistochemistry image analysis(Elsevier Ltd, 2022) Mathew, T.; Niyas, S.; Johnpaul, C.I.; Kini, J.; Rajan, J.Breast carcinoma has various subtypes based on the genetic factors involved in the pathogenesis of the malignancy. Identifying the exact subtype and providing targeted treatment to the patient can improve the survival chances. Molecular subtyping through immunohistochemistry analysis is a pathology procedure to determine the subtype of breast cancer. The existing manual procedure is tedious and involves assessing the status of the four vital molecular biomarkers present in the tumor tissues. In this paper, a deep learning-based framework for automated molecular subtyping of breast cancer is proposed. Digital slide images of the four biomarkers are separately processed by the proposed framework. In the preprocessing stage, the non-informative background regions from the images are separated. The patches extracted from the foreground regions are classified into target classes using convolutional neural network models trained for this purpose. Classification results are post-processed to predict the status of all the four biomarkers. The predictions for the individual biomarkers are finally consolidated as per clinical guidelines to determine the subtype of the cancer. The proposed system is evaluated for the performance of individual biomarker status prediction and patient-level subtype classification.For patient-level evaluation of biomarkers ER, PR, K67, and HER2, the proposed method gives F1 Scores 1.00, 1.00, 0.90, and 0.94 respectively, whereas for molecular subtyping an F1 score of 0.89 is obtained. In both these aspects, the proposed framework has given significant results that show the effectiveness of our approach. © 2022 Elsevier LtdItem Automated Molecular Subtyping of Breast Carcinoma Using Deep Learning Techniques(Institute of Electrical and Electronics Engineers Inc., 2023) Niyas, S.; Bygari, R.; Naik, R.; Viswanath, B.; Ugwekar, D.; Mathew, T.; Kavya, J.; Kini, J.R.; Rajan, J.Objective: Molecular subtyping is an important procedure for prognosis and targeted therapy of breast carcinoma, the most common type of malignancy affecting women. Immunohistochemistry (IHC) analysis is the widely accepted method for molecular subtyping. It involves the assessment of the four molecular biomarkers namely estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and antigen Ki67 using appropriate antibody reagents. Conventionally, these biomarkers are assessed manually by a pathologist, who finally combines individual results to identify the molecular subtype. Molecular subtyping necessitates the status of all the four biomarkers together, and to the best of our knowledge, no such automated method exists. This paper proposes a novel deep learning framework for automatic molecular subtyping of breast cancer from IHC images. Methods and procedures: A modified LadderNet architecture is proposed to segment the immunopositive elements from ER, PR, HER2, and Ki67 biomarker slides. This architecture uses long skip connections to pass encoder feature space from different semantic levels to the decoder layers, allowing concurrent learning with multi-scale features. The entire architecture is an ensemble of multiple fully convolutional neural networks, and learning pathways are chosen adaptively based on input data. The segmentation stage is followed by a post-processing stage to quantify the extent of immunopositive elements to predict the final status for each biomarker. Results: The performance of segmentation models for each IHC biomarker is evaluated qualitatively and quantitatively. Furthermore, the biomarker prediction results are also evaluated. The results obtained by our method are highly in concordance with manual assessment by pathologists. Clinical impact: Accurate automated molecular subtyping can speed up this pathology procedure, reduce pathologists' workload and associated costs, and facilitate targeted treatment to obtain better outcomes. © 2013 IEEE.Item A deep learning based classifier framework for automated nuclear atypia scoring of breast carcinoma(Elsevier Ltd, 2023) Mathew, T.; Johnpaul, C.I.; Ajith, B.; Kini, J.R.; Rajan, J.Nuclear atypia scoring is an essential procedure in the grading of breast carcinoma. Manual procedure of nuclear atypia scoring is error-prone, and marked by pathologists’ disagreement and low reproducibility. Automated methods are actively attempted by researchers to solve the problems of manual scoring. In this work, we propose a novel deep learning-based framework for automated nuclear atypia scoring of breast cancer from histopathology slide images. The framework consists of three major phases namely preprocessing, deep learning, and postprocessing. The original three-class problem of atypia scoring at slide level is not suitable for direct application of deep learning algorithms. This is due to the large dimensions and structural complexity of slide images, compounded by the small sample size of the available dataset. Redesign of this problem into a six-class nuclei classification problem through a set of preprocessing steps to facilitate effective use of deep learning algorithms, and the flexibility of the proposed three-phase framework to use different algorithms in each phase are the novel aspects of the proposed work. We used the publicly available slide image dataset MITOS-ATYPIA that contains 600 slide images of high spatial dimension for the experiments. A five-fold cross validation with the train-test sample ratio 80:20 in each fold is used for the performance evaluation. The performance of the method based on this framework exceeds the state-of-the-art with the results 0.8766, 0.8760, and 0.8745 for the metrics precision, recall, and F1 score respectively. © 2023 Elsevier LtdItem A Novel Decision Level Class-Wise Ensemble Method in Deep Learning for Automatic Multi-Class Classification of HER2 Breast Cancer Hematoxylin-Eosin Images(Institute of Electrical and Electronics Engineers Inc., 2024) Pateel, G.P.; Senapati, K.; Pandey, A.K.The Human Epidermal Growth Factor Receptor 2 (HER2) is one of the aggressive subtypes of breast cancer. The HER2 status decides the requirement of breast cancer patients to receive HER2-targeted therapy. The HER2 testing involves combining Immunohistochemistry (IHC) screening, followed by fluorescence in situ hybridization (FISH) for cases where IHC results are equivocal. These tests may involve multiple trials, are time intensive, and tend to be more expensive for certain classes of people. Hematoxylin and Eosin (HE) staining is employed for visualizing general tissue morphology and is a routine, cost-effective method. In this study, we introduce a novel automated class-wise weighted average ensemble deep learning algorithm at the decision level. The proposed algorithm fuses three pre-trained deep-learning models at the decision level by assigning a weight to each class based on their performance of the model to classify the HE-stained breast histopathology images into multi-class HER2 statuses as HER2-0+, HER2-1+, HER2-2+, and HER2-3+. The class-wise weight allocation to the base classifiers is one of the key features of the proposed algorithm. The presented framework surpasses all the existing methods currently employed on the Breast Cancer Immunohistochemistry (BCI) dataset, establishing itself as a dependable approach for detecting HER2 status from HE-stained images. This study highlights the robustness of the proposed algorithm as well as the sufficient information encapsulated within HE-stained images for the effective detection of the HER2 protein present in breast cancer. Therefore, the proposed method possesses the potential to sideline the need for IHC laboratory tests, which hoard time and money. © 2013 IEEE.Item Improving the performance of multi-stage HER2 breast cancer detection in hematoxylin-eosin images based on ensemble deep learning(Elsevier Ltd, 2025) Pateel, G.P.; Senapati, K.; Pandey, A.K.Background: Breast cancer is the most frequently diagnosed cancer among women worldwide, and histopathology is the gold standard in diagnosing the disease. Hematoxylin and Eosin (HE) staining, routinely employed to observe the overall tissue structure, is an affordable and commonly practiced cancer diagnosis. In contrast, Immunohistochemistry (IHC), which detects the increased presence of particular antigens linked to the mutation, can require multiple tests to conduct and is relatively costly. Generally, in computer-aided diagnosis, the conventional methods rely on a single network to extract features. However, these methods have significant limitations and fail to generalize. Methods: In this study, we propose an automated novel weighted average algorithm called HER2-ETNET, which ensembles the chosen three pre-trained deep learning models, DenseNet 201, GoogLeNet, and ResNet-50, to classify breast histopathology HE images into multi-class Human Epidermal Growth Factor Receptor-2 (HER2) status (HER2-0+, HER2-1+, HER2-2+, HER2-3+). The proposed method has the potential to bypass the IHC laboratory test. In this study, we form a weight matrix by fusing together, the scores of False Positive Rate (FPR) and False Negative Rate (FNR) of both training and validation sets, and the computed weights are assigned to the three base learners. This is in contrast to the previous works, in which the weights were generally assigned empirically to the chosen deep learning models, which might be erroneous. Result: The proposed approach is evaluated on the unseen test set, and it achieves accuracy, precision, recall and AUC of 97.44%, 97.32%, 97.39%, and 99.75% respectively. Conclusion: The proposed framework outperforms all the existing methods on the same dataset and is proven to be the reliable method in detecting the HER2 status (HER2-0+, HER2-1+, HER2-2+, HER2-3+) from HE images. This also proves that, HE stained images contain adequate information for efficiently detecting the HER2 status in breast cancer. © 2024 Elsevier Ltd